# Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

> **NCT01511523** · NA · UNKNOWN · sponsor: **Biovil Research Group, LLC** · enrollment: 40 (estimated)

## Conditions studied

- Non Alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** RGMA001
- **DIETARY_SUPPLEMENT:** Sugar Pill

## Key facts

- **NCT ID:** NCT01511523
- **Lead sponsor:** Biovil Research Group, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511523, "Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01511523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*